[Chinese expert consensus on the application of amniotic membrane in the treatment of corneal and ocular surface diseases (2023)].

Amniotic membrane (AM) can promote epithelialization, inhibit inflammation and be antimicrobial. It has been widely used in the clinical treatment of corneal epithelial and stromal defects. However, the misuse and abuse of AM might aggravate the primary disease and even lead to the loss of the best timing for other surgical interventions. Based on domestic and foreign clinical practice guidelines and medical evidence, the Cornea Group of Ophthalmology Branch of Chinese Medical Association has formed consensus opinions about the indications, surgical techniques and perioperative management of AM transplantation, so as to standardize the application of AM in the treatment of corneal and ocular surface diseases.